Exchange: OTC·Updated 11:31 AM EDT

NPHC Nutra Pharma Corp.

$0.0001
$0.00
(0.00%)
Today
Mkt Cap$715,973.00
Vol600,000.00

About NPHC

Nutra Pharma Corp. operates as a bio pharmaceutical company. The firm engages in the acquisition, licensing and commercialization of pharmaceutical products and technologies & homeopathic and ethical drugs for the management of pain, neurological disorders, autoimmune and infectious diseases. Its products are Cobroxin, which is used for an over-the-counter pain reliever designed to treat moderate to severe chronic pain and Nyloxin Extra Strength, which is used for stronger versions of Cobroxin. The company was founded on February 1, 2000 and is headquartered in Boca Raton, FL.
47

Neutral Sentiment

How do you feel about NPHC?

Sharesgreat
$NPHC One thing shareholders need to watch is the debt. As of 6/30/26, NPHC reported roughly $21.8M in total liabilities vs. only ~$623K in assets, including about $12.6M in notes/debt. If a new company/business is coming into NPHC, those liabilities don’t just disappear. They would have to be paid, settled, restructured or potentially converted into equity. That last part matters because issuing shares to satisfy convertible debt can mean significant dilution for existing shareholders. IMO, the big question isn’t just “What new company could NPHC become?” It’s “How will the existing debt and liabilities be handled, and what will the share structure look like afterward?” That could ultimately determine what current common shareholders are left owning.
4
FireInvestment
$NPHC After talking with some people it sounds like they might be gearing up to making NPHC a new company, how would that fair for us shareholders.

Advertisement|Remove ads.